ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #11,187Hybrid

International Journal of Peptide Research and Therapeutics

Abbreviation (ISO):INT. J. PEPT. RES. THER
•
Identifier (ISSN):1573-3149(Print)/1573-3904(Online)
•
Publisher:Springer Netherlands
Clarivate IF (2026)
2.5↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for International Journal of Peptide Research and Therapeutics

WoS Q3
01341.1320181.2220191.520201.9320212.1920222.52023220242.420252.52026
Annual Impact Factor Metric
Current (2026):2.5
Scopus SJR & RankScopus Q2
0.532
#11,187

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
53

53 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
154articles/year
12.2% Gold OA•92.44% Original Research

Aims & Scope

The International Journal for Peptide Research & Therapeutics is an international, peer-reviewed journal focusing on issues, research, and integration of knowledge on the latest developments in peptide therapeutics. The Journal brings together in a single source the most exciting work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives. The Journal invites substantial contributions in the following thematic areas: -New advances in peptide drug delivery systems. -Application of peptide therapeutics to specific diseases. -New advances in synthetic methods. -The development of new procedures for construction of peptide libraries and methodology for screening of such mixtures. -The use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions -Applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography, mass spectrometry.

Topics Covered (Recognized by AI)
Biology98.3%Chemistry95.5%Biochemistry92.1%Genetics85.6%Medicine70%Physics63.3%Nuclear magnetic resonance58.9%Organic chemistry56%Internal medicine48.6%Peptide43.1%Gene38.4%Immunology28.6%Geology25.3%Enzyme24.1%Paleontology23.9%Microbiology21.9%Endocrinology21.7%Computational biology21%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q3
Rank236/328
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q4
Rank249/328
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.5
Articles / Year74
Total Citations15
2025
IF2.4
Articles / Year115
Total Citations266
2024
IF2
Articles / Year86
Total Citations355
2023
IF2.5
Articles / Year97
Total Citations838
2022
IF2.191
Articles / Year141
Total Citations1,499

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,187Scopus Q2SCImago Profile
Scopus Coverage:1996-2002, 2005-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyChemical EngineeringChemistryPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.532

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.96

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,855 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations982
3-Year Documents337
Citable Documents335

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Analytical ChemistryQ2
BiochemistryQ3
BioengineeringQ3
Drug DiscoveryQ3
Molecular MedicineQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Biology
Minor Category (Specific Field):
4区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

International Journal of Peptide Research and Therapeutics (abbr: INT. J. PEPT. RES. THER, ISSN: 1573-3149) is a peer-reviewed international scholarly journal in the field of Biology, published by Springer Netherlands in United States since 1994. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.532 (Q2), an H-index of 53.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 154 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,855 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Netherlands
Publication Language
English
Frequency
Quarterly
Founding Year
1994
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: cd4571c5-2098-4296-850e-6aabb253ef1a
Database Updated: 2026-09-28